{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:09:25Z","timestamp":1790834965777,"version":"4.1.0"},"reference-count":35,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Iron deficiency (ID) is prevalent in congestive heart failure (CHF), worsening outcomes. While European guidelines recommend screening using ferritin and transferrin-saturation (TSAT), inconsistent diagnostic criteria, especially regarding functional deficiency (ferritin 100\u2013299 \u03bcg\/L + TSAT &lt; 20%) and hyperferritinemia, limit prognostic accuracy. This study evaluated iron status definitions, including guideline criteria and a combined Ferritin-TSAT model, for predicting 365-day mortality in hospitalised CHF patients. Methods: This retrospective analysis used MIMIC-IV data from 1839 CHF patients. Iron status within 24 h of admission was categorised using: (1) Guideline ID vs. non-ID; (2) Ferritin categories; (3) TSAT categories; (4) Combined Ferritin-TSAT model (Low: guideline ID; Intermediate: ferritin 100\u2013299 + TSAT \u2265 20%; High: ferritin \u2265 300 \u03bcg\/L). Adjusted Cox models assessed mortality associations. Results: Guidelines-defined iron deficiency (33.66% prevalence) independently associated with higher 1-year mortality (56.1% vs. 29.4%; adjusted HR 4.36, 95% CI 3.35\u20135.34). The combined Ferritin-TSAT model showed significant prognostic value, differentiating true iron deficiency (reference) from hyperferritinemia (adjusted HR 0.50 vs. iron deficiency) and intermediate group (adjusted HR 0.36 vs. ID), indicating varying risk relative to the most deficient group. This combined model better distinguished hyperferritinemic and iron-replete subgroups than the binary guideline definition. Conclusions: Iron status, including deficiency and hyperferritinemia, independently predicts 1-year mortality in CHF. While guideline iron deficiency is a strong predictor, a combined Ferritin-TSAT classification offers finer risk stratification by identifying distinct phenotypes (true deficiency, hyperferritinemia, intermediate). Nuanced iron status assessment could improve prognostic evaluation and guide personalised therapies (e.g., IV iron for deficiency, investigation for hyperferritinemia) to enhance CHF outcomes.<\/jats:p>","DOI":"10.3390\/jcm15010244","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:50:42Z","timestamp":1766969442000},"page":"244","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Value of Different Iron Status Definitions in Congestive Heart Failure: A Retrospective MIMIC-IV Analysis of Risk Stratification and Mortality"],"prefix":"10.3390","volume":"15","author":[{"given":"Abdulla Zahi","family":"Hourani","sequence":"first","affiliation":[{"name":"Faculty of Medicine, English Division, Medical University of Warsaw, 02-091 Warsaw, Poland"},{"name":"Department and Clinic of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman David","family":"S\u00fcrmeli","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, English Division, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1098-3811","authenticated-orcid":false,"given":"Sai Keertana","family":"Devarapalli","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, English Division, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: An international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am. Heart. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","article-title":"Disordered iron homeostasis in chronic heart failure: Prevalence, predictors, and relation to anaemia, exercise capacity, and survival","volume":"58","author":"Okonko","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/00015385.2017.1351239","article-title":"Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction","volume":"73","author":"Martens","year":"2018","journal-title":"Acta Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis treatment of acute chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis treatment of acute chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Maidana, D., Arroyo-\u00c1lvarez, A., Barreres-Mart\u00edn, G., Arenas-Loriente, A., Cepas-Guillen, P., Brigolin Garofo, R.T., Caravaca-P\u00e9rez, P., and Bonanad, C. (2025). Targeting Inflammation and Iron Deficiency in Heart Failure: A Focus on Older Adults. Biomedicines, 13.","DOI":"10.20944\/preprints202501.0154.v1"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: Regulation of Mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100873","DOI":"10.1016\/j.mam.2020.100873","article-title":"Iron deficiency and supplementation in heart failure and chronic kidney disease","volume":"75","author":"Punj","year":"2020","journal-title":"Mol. Asp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3345\/cep.2023.01732","article-title":"Absolute versus functional iron deficiency","volume":"68","author":"Jung","year":"2025","journal-title":"Clin. Exp. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anaemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Sindone, A., Doehner, W., Manito, N., McDonagh, T., Cohen-Solal, A., Damy, T., N\u00fa\u00f1ez, J., Pfister, O., van der Meer, P., and Comin-Colet, J. (2022). Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?. J. Clin. Med., 11.","DOI":"10.3390\/jcm11112976"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jjcc.2023.06.012","article-title":"Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomised clinical trials","volume":"83","author":"Bhatia","year":"2024","journal-title":"J. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00392-021-01837-8","article-title":"Intravenous iron for heart failure with evidence of iron deficiency: A meta-analysis of randomised trials","volume":"110","author":"Graham","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ehf2.14905","article-title":"Intravenous iron therapy for heart failure and iron deficiency: An updated meta-analysis of randomised clinical trials","volume":"12","author":"Ahmed","year":"2025","journal-title":"ESC Heart Fail."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cardfail.2023.03.025","article-title":"Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America","volume":"29","author":"Beavers","year":"2023","journal-title":"J. Card. Fail."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.124.068883","article-title":"Redefining Iron Deficiency in Patients with Chronic Heart Failure","volume":"150","author":"Packer","year":"2024","journal-title":"Circulation"},{"key":"ref_17","first-page":"63","article-title":"Iron Deficiency and Its Treatment in Heart Failure: Indications and Effect on Prognosis","volume":"14","author":"Kocyigit","year":"2016","journal-title":"E-J. Cardiol. Pract."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1093\/eurheartj\/ehad586","article-title":"Efficacy of ferric carboxymaltose in heart failure with iron deficiency: An individual patient data meta-analysis","volume":"44","author":"Ponikowski","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci. Data"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"ooaf092","DOI":"10.1093\/jamiaopen\/ooaf092","article-title":"EchoLLM: Extracting echocardiogram entities with light-weight, open-source large language models","volume":"8","author":"Chi","year":"2025","journal-title":"JAMIA Open"},{"key":"ref_21","first-page":"1877","article-title":"Language Models are Few-Shot Learners","volume":"33","author":"Brown","year":"2020","journal-title":"Adv. Neural Inf. Process. Syst. (NeurIPS)"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Gao, T., Fisch, A., and Chen, D. (2021, January 1\u20136). Making Pre-trained Language Models Better Few-Shot Learners. Proceedings of the 59th Annual Meeting of the Association for Computational Linguistics (ACL), Bangkok, Thailand.","DOI":"10.18653\/v1\/2021.acl-long.295"},{"key":"ref_23","unstructured":"Bain, B.J., Bates, I., and Laffan, M.A. (2017). Iron deficiency anaemia and iron overload. Dacie and Lewis Practical Haematology, Elsevier. [12th ed.]."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/01.ATV.0000174126.28201.61","article-title":"Iron stores and vascular function in voluntary blood donors","volume":"25","author":"Zheng","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","article-title":"Iron deficiency and heart failure: Diagnostic dilemmas and therapeutic perspectives","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for Iron Deficiency in Patients with Heart Failure","volume":"79","author":"Masini","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e004519","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of Iron Deficiency Based on the Gold Standard of Bone Marrow Iron Staining in Heart Failure Patients","volume":"11","author":"Klip","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamacardio.2019.1739","article-title":"Differences in Clinical Profile and Outcomes of Low Iron Storage vs. Defective Iron Utilisation in Patients with Heart Failure: Results from the DEFINE-HF and BIOSTAT-CHF Studies","volume":"4","author":"Beverborg","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e011440","DOI":"10.1161\/CIRCHEARTFAILURE.123.011440","article-title":"Defining Iron Deficiency in Heart Failure: Importance of Transferrin Saturation","volume":"17","author":"Martens","year":"2024","journal-title":"Circ. Heart Fail."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"123371","DOI":"10.1016\/j.jns.2024.123371","article-title":"The prognostic role of iron deficiency in acute ischemic stroke patients: A prospective multicentric cohort study","volume":"469","author":"Ciacciarelli","year":"2025","journal-title":"J. Neurol. Sci."},{"key":"ref_31","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mancardi, D., Mezzanotte, M., Arrigo, E., Barinotti, A., and Roetto, A. (2021). Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver. Antioxidants, 10.","DOI":"10.3390\/antiox10121864"},{"key":"ref_33","first-page":"102662","article-title":"Iron Deficiency Definitions in Heart Failure Across Ejection Fraction Phenotypes: Prevalence, Symptoms, and Cause-Specific Outcomes","volume":"13","author":"Lindberg","year":"2025","journal-title":"J. Am. Coll. Cardiol. Heart Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/eurheartj\/ehae086","article-title":"Intravenous iron for heart failure, iron deficiency definitions, and clinical response: The IRONMAN trial","volume":"45","author":"Cleland","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Vasques-N\u00f3voa, F., Pimentel, M.J., Marques, P., Vale, C., Gomes, F., Neves, J.S., Barroso, I., Guimar\u00e3es, J.T., Bettencourt, P., and Leite-Moreira, A.F. Ferritin, inflammation, and iron deficiency in acute heart failure: Evidence from the EDIFICA cohort. Clin. Res. Cardiol., 2024, Epub ahead of print.","DOI":"10.1007\/s00392-024-02535-x"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/244\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:51:18Z","timestamp":1767192678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15010244"],"URL":"https:\/\/doi.org\/10.3390\/jcm15010244","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,28]]}}}